Outi M. H. Salo-Ahen

Navedeno

	Vse	Od leta 2020
Navedbe	2537	1349
indeks h	26	18
indeks i10	42	31

400

200

100

300

20052006200720082009201020112012201320142015201620172018201920202021202220232024202514 32 60 78 86 80 75 90 107 94 101 87 65 105 98 163 196 231 275 390 93

Javni dostop

Prikaži vse

23 člankov

1 članek

na voljo

ni na voljo

Na podlagi zahtev v povezavi s financiranjem

Soavtorji

Rebecca WadeHeidelberg Institute for Theoretical Studies and Heidelberg UniversityPreverjeni e-poštni naslov na h-its.org
Rajendra Bhadane, PhD (Pharmacy)University of TurkuPreverjeni e-poštni naslov na utu.fi
Antti PosoProfessor of Drug Design, University of Eastern FinlandPreverjeni e-poštni naslov na uef.fi
Muhammad Usman MirzaDepartment of Chemistry and Biochemistry, University of Windsor, ON, CanadaPreverjeni e-poštni naslov na uwindsor.ca
Michiel VanmeertPhD Pharmaceutical Sciences | Pharmacist | master economicsPreverjeni e-poštni naslov na kuleuven.be
Costi Maria PaolaMedicinal chemistry professor University of Modena and Reggio EmiliaPreverjeni e-poštni naslov na unimore.it
Parthiban MarimuthuÅbo Akademi UniversityPreverjeni e-poštni naslov na abo.fi
Stefania FerrariDepartment of Life Sciences, Unversity of Modena and Reggio EmiliaPreverjeni e-poštni naslov na unimore.it
Jessica RosenholmProfessor in Pharmaceutical Development, Pharmaceutical Sciences Laboratory, Åbo Akademi UniversityPreverjeni e-poštni naslov na abo.fi
Ghulam MustafaLeibniz-Institute for Food Systems Biology at TUM: Freising, Baveria , DEPreverjeni e-poštni naslov na tum.de
mathy froeyenKU LeuvenPreverjeni e-poštni naslov na rega.kuleuven.be
STEFANO MANGANIDepartment of Biotechnology, Chemistry and Pharmacy University of SienaPreverjeni e-poštni naslov na unisi.it
Giambattista GuaitoliDZNE - Deutsches Zentrum Neurodegerative ErkrankungenPreverjeni e-poštni naslov na dzne.de
Hongbo ZhangProfessor in Pharmaceutical Biomaterials, Åbo Akademi UniversityPreverjeni e-poštni naslov na abo.fi
Shakhawath HossainResearcher, Uppsala UniversityPreverjeni e-poštni naslov na farmaci.uu.se
Rodrigo Vargas HonoratoUtrecht University - Computational Structural Biology LabPreverjeni e-poštni naslov na uu.nl
Aleksei KabedevResearcher, Uppsala UniversityPreverjeni e-poštni naslov na farmaci.uu.se
Anders Støttrup LarsenPhD, University of CopenhagenPreverjeni e-poštni naslov na sund.ku.dk
Kalaimathy SingaraveluUniversity of TurkuPreverjeni e-poštni naslov na utu.fi
Prof. Dr. Muhammad IdreesCEMB, University of the Punjab; FormerVC, Hazara University; Vice-Chancellor, University of PeshawarPreverjeni e-poštni naslov na pu.edu.pk

Spremljaj

Outi M. H. Salo-Ahen

Adjunct Professor (Docent), Senior University Lecturer, Åbo Akademi University

Preverjeni e-poštni naslov na abo.fi

computer-aided drug design molecular modeling molecular dynamics antimicrobials natural compounds


Naslov Razvrsti po navedbah Razvrsti po letniku Razvrsti po naslovu	Navedeno Navedeno	Leto
Molecular dynamics simulations in drug discovery and pharmaceutical development OMH Salo-Ahen, I Alanko, R Bhadane, AMJJ Bonvin, RV Honorato, ... Processes 9 (1), 71, 2020	414	2020
Computational approaches to identifying and characterizing protein binding sites for ligand design S Henrich, OMH Salo‐Ahen, B Huang, FF Rippmann, G Cruciani, ... Journal of Molecular Recognition: An Interdisciplinary Journal 23 (2), 209-219, 2010	264	2010
Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes SM Saario, OMH Salo, T Nevalainen, A Poso, JT Laitinen, T Järvinen, ... Chemistry & biology 12 (6), 649-656, 2005	196	2005
Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins M Usman Mirza, S Rafique, A Ali, M Munir, N Ikram, A Manan, ... Scientific reports 6 (1), 37313, 2016	137	2016
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL^pro MA Alamri, M Tahir ul Qamar, MU Mirza, R Bhadane, SM Alqahtani, ... Journal of Biomolecular Structure and Dynamics 39 (13), 4936-4948, 2021	113	2021
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase D Cardinale, G Guaitoli, D Tondi, R Luciani, S Henrich, OMH Salo-Ahen, ... Proceedings of the National Academy of Sciences 108 (34), E542-E549, 2011	109	2011
Development of a 3D model for the human cannabinoid CB1 receptor OMH Salo, M Lahtela-Kakkonen, J Gynther, T Järvinen, A Poso Journal of medicinal chemistry 47 (12), 3048-3057, 2004	106	2004
Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands KH Raitio, OMH Salo, T Nevalainen, A Poso, T Jarvinen Current medicinal chemistry 12 (10), 1217-1237, 2005	87	2005
CB receptor ligands from plants R Bauer, K Woelkart, OMH Salo-Ahen Current Topics in Medicinal Chemistry 8 (3), 173-186, 2008	77	2008
Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system SM Saario, A Poso, RO Juvonen, T Järvinen, OMH Salo-Ahen Journal of medicinal chemistry 49 (15), 4650-4656, 2006	77	2006
Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor OMH Salo, KH Raitio, JR Savinainen, T Nevalainen, M Lahtela-Kakkonen, ... Journal of medicinal chemistry 48 (23), 7166-7171, 2005	76	2005
Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis B Jabbar, S Rafique, OMH Salo-Ahen, A Ali, M Munir, M Idrees, MU Mirza, ... Frontiers in Immunology (Viral Immunology) 9 (Article 3000), 10.3389/fimmu …, 2018	67	2018
Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs D Garg, S Henrich, OMH Salo-Ahen, H Myllykallio, MP Costi, RC Wade Journal of medicinal chemistry 53 (18), 6539-6549, 2010	64	2010
Identification of WIN55212‐3 as a competitive neutral antagonist of the human cannabinoid CB₂ receptor JR Savinainen, T Kokkola, OMH Salo, A Poso, T Järvinen, JT Laitinen British journal of pharmacology 145 (5), 636-645, 2005	60	2005
Homodimeric enzymes as drug targets D Cardinale, OMH Salo-Ahen, S Ferrari, G Ponterini, G Cruciani, ... Current medicinal chemistry 17 (9), 826-846, 2010	57	2010
Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems C Sahlgren, A Meinander, H Zhang, F Cheng, M Preis, C Xu, TA Salminen, ... Advanced healthcare materials, 2017	43	2017
Dynamics of CYP51: implications for function and inhibitor design X Yu, V Cojocaru, G Mustafa, OMH Salo‐Ahen, GI Lepesheva, RC Wade Journal of Molecular Recognition 28 (2), 59-73, 2015	42	2015
Inhibition of oncogenic kinases: An in vitro validated computational approach identified potential multi-target anticancer compounds N Ikram, MU Mirza, M Vanmeert, M Froeyen, OMH Salo-Ahen, M Tahir, ... Biomolecules 9 (4), 124, 2019	36	2019
Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes 2020; 9 (1): 71 OMH Salo-Ahen, I Alanko, R Bhadane, A Bonvin, RV Honorato, ...	33
Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy J Yan, R Bhadane, M Ran, X Ma, Y Li, D Zheng, OMH Salo-Ahen, ... Nature Communications 15 (1), 3684, 2024	32	2024

Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.

Članki 1–20

Št. navedb na leto

Podvojene navedbe

Združene navedbe

Dodajanje soavtorjevSoavtorji

Spremljaj

Navedeno

Soavtorji